Verséa Discovery has launched its novel research tool, mescreen Research Validator, designed to collect crucial data on mitochondrial function, assisting in developing, formulating, and clinically validating various health-related products.
mescreen leverages patented bioassay, imaging, and ML methods to provide insights into mitochondrial efficiency and the clinical impacts of different test substances. The platform is claimed to have assisted research by analyzing over 60 FDA-approved compounds and agents known to affect mitochondrial function. The company is developing a mescreen-personalized mitochondrial efficiency test to offer individuals a detailed energy profile for enhancing their overall well-being.
Verséa Discovery specializes in developing cutting-edge research platforms and personalized medicine solutions.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.